These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 30630955)

  • 1. Inflammatory markers in Alzheimer's disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies.
    Shen XN; Niu LD; Wang YJ; Cao XP; Liu Q; Tan L; Zhang C; Yu JT
    J Neurol Neurosurg Psychiatry; 2019 May; 90(5):590-598. PubMed ID: 30630955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial activation and inflammation along the Alzheimer's disease continuum.
    Nordengen K; Kirsebom BE; Henjum K; Selnes P; Gísladóttir B; Wettergreen M; Torsetnes SB; Grøntvedt GR; Waterloo KK; Aarsland D; Nilsson LNG; Fladby T
    J Neuroinflammation; 2019 Feb; 16(1):46. PubMed ID: 30791945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal Ordering of Inflammatory Analytes sTNFR2 and sTREM2 in Relation to Alzheimer's Disease Biomarkers and Clinical Outcomes.
    Pillai JA; Khrestian M; Bena J; Leverenz JB; Bekris LM
    Front Aging Neurosci; 2021; 13():676744. PubMed ID: 34276339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble TREM2 changes during the clinical course of Alzheimer's disease: A meta-analysis.
    Liu D; Cao B; Zhao Y; Huang H; McIntyre RS; Rosenblat JD; Zhou H
    Neurosci Lett; 2018 Nov; 686():10-16. PubMed ID: 30171911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort.
    Kester MI; Teunissen CE; Sutphen C; Herries EM; Ladenson JH; Xiong C; Scheltens P; van der Flier WM; Morris JC; Holtzman DM; Fagan AM
    Alzheimers Res Ther; 2015 Sep; 7(1):59. PubMed ID: 26383836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral inflammatory biomarkers in Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis.
    Su C; Zhao K; Xia H; Xu Y
    Psychogeriatrics; 2019 Jul; 19(4):300-309. PubMed ID: 30790387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-33 and its decoy sST2 in patients with Alzheimer's disease and mild cognitive impairment.
    Saresella M; Marventano I; Piancone F; La Rosa F; Galimberti D; Fenoglio C; Scarpini E; Clerici M
    J Neuroinflammation; 2020 Jun; 17(1):174. PubMed ID: 32505187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of visinin-like protein 1 concentrations in the cerebrospinal fluid of patients with mild cognitive impairment as a dynamic biomarker of Alzheimer's disease.
    Mroczko B; Groblewska M; Zboch M; Muszyński P; Zajkowska A; Borawska R; Szmitkowski M; Kornhuber J; Lewczuk P
    J Alzheimers Dis; 2015; 43(3):1031-7. PubMed ID: 25159667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble TREM2 levels associate with conversion from mild cognitive impairment to Alzheimer's disease.
    Zhao A; Jiao Y; Ye G; Kang W; Tan L; Li Y; Deng Y; Liu J;
    J Clin Invest; 2022 Dec; 132(24):. PubMed ID: 36519540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of soluble TREM2 with Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis.
    Wang R; Zhan Y; Zhu W; Yang Q; Pei J
    Front Aging Neurosci; 2024; 16():1407980. PubMed ID: 38841103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis on the levels of VILIP-1 in the CSF of Alzheimer's disease compared to normal controls and other neurodegenerative conditions.
    Mavroudis IA; Petridis F; Chatzikonstantinou S; Karantali E; Kazis D
    Aging Clin Exp Res; 2021 Feb; 33(2):265-272. PubMed ID: 31939203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of TREM2 in peripheral cells from mild cognitive impairment patients who progress into Alzheimer's disease.
    Casati M; Ferri E; Gussago C; Mazzola P; Abbate C; Bellelli G; Mari D; Cesari M; Arosio B
    Eur J Neurol; 2018 Jun; 25(6):805-810. PubMed ID: 29377401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia.
    Olsson B; Hertze J; Lautner R; Zetterberg H; Nägga K; Höglund K; Basun H; Annas P; Lannfelt L; Andreasen N; Minthon L; Blennow K; Hansson O
    J Alzheimers Dis; 2013; 33(1):45-53. PubMed ID: 22890100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease.
    Diniz BS; Teixeira AL; Ojopi EB; Talib LL; Mendonça VA; Gattaz WF; Forlenza OV
    J Alzheimers Dis; 2010; 22(4):1305-11. PubMed ID: 20930310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Relationship between Markers of Inflammation and Degeneration in the Central Nervous System and the Blood-Brain Barrier Impairment in Alzheimer's Disease.
    Muszyński P; Kulczyńska-Przybik A; Borawska R; Litman-Zawadzka A; Słowik A; Klimkowicz-Mrowiec A; Pera J; Dziedzic T; Mroczko B
    J Alzheimers Dis; 2017; 59(3):903-912. PubMed ID: 28697565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble TREM2 Concentrations in the Cerebrospinal Fluid Correlate with the Severity of Neurofibrillary Degeneration, Cognitive Impairment, and Inflammasome Activation in Alzheimer's Disease.
    Španić Popovački E; Babić Leko M; Langer Horvat L; Brgić K; Vogrinc Ž; Boban M; Klepac N; Borovečki F; Šimić G
    Neurol Int; 2023 Jul; 15(3):842-856. PubMed ID: 37489359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Let's talk about sex, inflammaging, and cognition, baby": A meta-analysis and meta-regression of 106 case-control studies on mild cognitive impairment and Alzheimer's disease.
    Childs R; Karamacoska D; Lim CK; Steiner-Lim GZ
    Brain Behav Immun Health; 2024 Oct; 40():100819. PubMed ID: 39161876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease.
    Hellwig K; Kvartsberg H; Portelius E; Andreasson U; Oberstein TJ; Lewczuk P; Blennow K; Kornhuber J; Maler JM; Zetterberg H; Spitzer P
    Alzheimers Res Ther; 2015 Dec; 7():74. PubMed ID: 26698298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Inflammasome Adaptor Protein ASC in Mild Cognitive Impairment and Alzheimer's Disease.
    Scott XO; Stephens ME; Desir MC; Dietrich WD; Keane RW; de Rivero Vaccari JP
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32630059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the diagnostic value of peripheral BDNF levels for Alzheimer's disease and mild cognitive impairment: results of a meta-analysis.
    Xie B; Zhou H; Liu W; Yu W; Liu Z; Jiang L; Zhang R; Cui D; Shi Z; Xu S
    Int J Neurosci; 2020 Mar; 130(3):218-230. PubMed ID: 31518516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.